Medicine Shortages Information InitiativeTGA Australia
The presentation was given by the TGA at the 2014 ARCS Scientific Congress, and covers TGA's implementation of the Medicine Shortages Information Initiative
The document discusses challenges consumers face in the current healthcare system such as uncoordinated care, lack of chronic care management, and poor communication. It proposes that Accountable Care Organizations (ACOs) could help address these issues if designed properly with a focus on patient-centered care. Key elements identified for patient-centered ACOs include comprehensive care coordination, ready access to care teams, and engaging patients in shared decision making. However, the document cautions that ACOs must be developed collaboratively with consumers to ensure they meet patient needs and preferences in order to be successfully adopted.
Rare disease stakeholder dynamics pmrg institute fall 2014azdybak
This document discusses stakeholders in the rare disease space including patients, physicians, payers, manufacturers, and advocacy organizations. It notes that there are over 6,800 known rare diseases affecting 25-30 million Americans. The main stakeholders want access to new treatment options but payers aim to control rising specialty drug costs. Manufacturers charge high prices for rare disease drugs due to the small patient populations.
Rush Medical Survey Executive Summary 1David Donohue
Many consumers want major changes to the healthcare system including greater online access to providers, medical records, and customized insurance coverage. A survey of over 1,100 former patients at Rush University Medical Center found that consumers want simpler healthcare information and instructions. At the same time, consumers are anxious about rising costs and are seeking alternative medicines and services. However, many are also willing to pay more for wellness programs and support tax increases to cover the uninsured. The survey identifies opportunities for healthcare providers, insurers, employers and policymakers to address gaps between what consumers want and currently receive from the healthcare system.
In a health care system where consumers are empowered to actively choose among health plans, providers, and treatment options, delivering a satisfying customer experience is key to differentiation. The first step towards winning in a consumer-centric marketplace: understand how this new informed and engaged consumer views the health care system and how they define quality and value.
For more, check out the full report on the quest for value in health care: https://www.deloitte.com/view/en_US/us/Insights/centers/center-for-health-solutions/b57d260a4ac35410VgnVCM3000003456f70aRCRD.htm
Weitzman 2013: State Health Policy Initiatives as Drivers for Improving Care...CHC Connecticut
Sue Birch presents on State Health Policy Initiatives as Drivers for Improving Care Outcomes: Colorado's Accountable Care Collaborative at the 2013 Weitzman Symposium
Telehealth Secrets 2019: Disruption in Healthcare: What's Next? - Randy Parke...VSee
The document discusses how to disrupt the pharmacy experience by increasing transparency, education, and access to lower drug costs. It identifies over $800 billion in potential savings and outlines solutions like telepharmacy, digital therapeutics, analytics, virtual reality therapies, and advanced 3D printed medications. The goal is to create a more cost effective and personalized pharmacy experience of the future.
Medicine Shortages Information InitiativeTGA Australia
The presentation was given by the TGA at the 2014 ARCS Scientific Congress, and covers TGA's implementation of the Medicine Shortages Information Initiative
The document discusses challenges consumers face in the current healthcare system such as uncoordinated care, lack of chronic care management, and poor communication. It proposes that Accountable Care Organizations (ACOs) could help address these issues if designed properly with a focus on patient-centered care. Key elements identified for patient-centered ACOs include comprehensive care coordination, ready access to care teams, and engaging patients in shared decision making. However, the document cautions that ACOs must be developed collaboratively with consumers to ensure they meet patient needs and preferences in order to be successfully adopted.
Rare disease stakeholder dynamics pmrg institute fall 2014azdybak
This document discusses stakeholders in the rare disease space including patients, physicians, payers, manufacturers, and advocacy organizations. It notes that there are over 6,800 known rare diseases affecting 25-30 million Americans. The main stakeholders want access to new treatment options but payers aim to control rising specialty drug costs. Manufacturers charge high prices for rare disease drugs due to the small patient populations.
Rush Medical Survey Executive Summary 1David Donohue
Many consumers want major changes to the healthcare system including greater online access to providers, medical records, and customized insurance coverage. A survey of over 1,100 former patients at Rush University Medical Center found that consumers want simpler healthcare information and instructions. At the same time, consumers are anxious about rising costs and are seeking alternative medicines and services. However, many are also willing to pay more for wellness programs and support tax increases to cover the uninsured. The survey identifies opportunities for healthcare providers, insurers, employers and policymakers to address gaps between what consumers want and currently receive from the healthcare system.
In a health care system where consumers are empowered to actively choose among health plans, providers, and treatment options, delivering a satisfying customer experience is key to differentiation. The first step towards winning in a consumer-centric marketplace: understand how this new informed and engaged consumer views the health care system and how they define quality and value.
For more, check out the full report on the quest for value in health care: https://www.deloitte.com/view/en_US/us/Insights/centers/center-for-health-solutions/b57d260a4ac35410VgnVCM3000003456f70aRCRD.htm
Weitzman 2013: State Health Policy Initiatives as Drivers for Improving Care...CHC Connecticut
Sue Birch presents on State Health Policy Initiatives as Drivers for Improving Care Outcomes: Colorado's Accountable Care Collaborative at the 2013 Weitzman Symposium
Telehealth Secrets 2019: Disruption in Healthcare: What's Next? - Randy Parke...VSee
The document discusses how to disrupt the pharmacy experience by increasing transparency, education, and access to lower drug costs. It identifies over $800 billion in potential savings and outlines solutions like telepharmacy, digital therapeutics, analytics, virtual reality therapies, and advanced 3D printed medications. The goal is to create a more cost effective and personalized pharmacy experience of the future.
Making informal health providers work better for the poor: Lessons from Niger...Jeff Knezovich
The document summarizes experiences with informal health providers in Nigeria and Bangladesh and lessons learned from interventions to improve their performance. In both countries, informal providers are an important source of healthcare for the poor but often provide low-quality and unnecessary treatment. Interventions involved training providers, establishing quality standards, and partnerships between organizations. This led to some improvements but also highlighted the need for sustainable business models and strategic leadership given political influences. Ongoing work includes learning platforms to further engage governments and improve market systems for the poor.
CINs (Clinically Integrated Networks) are groups of healthcare providers that work to improve care, reduce costs, and maintain quality standards. They create structures to manage value-based contracts, allow providers to demonstrate value, and integrate physicians and health systems. Key elements of CINs include collaborative physician governance, a focus on population health through data sharing and care management, health IT infrastructure, and aligning provider incentives through value-based contracts and shared savings. Providers commit to engaging with the network, focusing on quality metrics, and using resources to standardize care. In return, CINs provide opportunities for shared savings contracts and support providers through committees and performance feedback.
This document outlines research priorities related to improving health systems and community care. It identifies priorities such as exploring how other jurisdictions have organized health systems to improve outcomes and reduce costs, ensuring the needs of vulnerable populations are met, and redesigning mental health and addiction services to improve access and outcomes. Other priorities include exploring models of integrated health and social services, enhancing care transitions between settings and sectors, developing housing support options, expanding self-management support, and redesigning community care and payment systems to improve care coordination and reduce system utilization.
Dr. Craig J. Lenz - School of Osteopathic MedSamantha Haas
This document discusses barriers to telehealth and opportunities to integrate medical education and telehealth. It describes an early telehealth program in San Bernardino County, California that helped address barriers to care from distance. The document also discusses piloting the use of video conferencing units at a medical school to help deliver certain specialties and clinical education remotely, as well as the potential for students on international clerkships to participate in morning report back at the medical school via laptop or iPad.
This infographic speaks to the challenges Emergency Departments face in caring and following up with the growing population of patients they see, and demonstrates how some EDs are seeing measurable improvements in care, patient satisfaction and efficiency.
Weitzman 2013: PCORI: Transforming Health CareCHC Connecticut
This document summarizes a presentation given by Joe Selby on the Patient-Centered Outcomes Research Institute (PCORI). It discusses PCORI's mission to fund comparative clinical effectiveness research that is guided by patients and other stakeholders. Key points include: PCORI's focus on research questions of interest to patients and providers; its criteria for funding proposals, including patient-centeredness and engagement; and its plans to significantly increase funding for such research over time. Examples are given of funded pilot projects involving community health centers.
General information and trends in continuing medical education (CME), based on Accreditation Council for Continuing Medical Education (ACCME) 2012 Annual Report data and general market analysis for trends impacting education participation.
Study on the Attitude of Medical Partitioners towardAnjum Kazimi
This document summarizes a study on the attitudes of medical practitioners in Pakistan towards social accountability. It describes the study's objectives to investigate medical practitioners' knowledge, attitudes, and practices related to social accountability. The methodology included surveys and interviews with 120 doctors. The results found the practitioners had average knowledge of social accountability but varying attitudes. Their attitudes were not strongly oriented towards social responsibility. The researchers recommend including social accountability training in medical curricula to improve practitioners' knowledge and attitudes.
The document provides a summary of Manjula Sonti's qualifications and experience as a licensed pharmacist. She has over 16 years of experience in retail and hospital pharmacy settings. She is currently pursuing a Master's degree in Health Informatics. Her experience includes managing pharmacy staff and inventory, dispensing and compounding prescriptions, educating patients, and interacting with insurance providers. She has demonstrated leadership, strong communication skills, and a track record of providing quality patient care.
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Parata Systems
Your pharmacy is an excellent partner for accountable care organizations. ACOs are formed by doctors, hospitals and other healthcare providers to improve health outcomes and lower overall medical expenses for a targeted patient population. Reimbursements are tied to patient outcomes.
ACOs’ highest-risk and highest-cost patients are those managing chronic illnesses and taking multiple medications a day. When your pharmacy can improve and track adherence – a key driver of readmission prevention and overall health – you are a valuable partner to help ACOs prevent unnecessary medical care.
Jamie Hale serves as the Chief Pharmacy Officer for Cornerstone Health Care where he is responsible for the development and integration of pharmaceutical care services in the Accountable Care Organization. He transitioned to Cornerstone in December 2012 after a 15 year career at Wake Forest Baptist Health, where he last served as Director of Pharmacy.
Download the full audio webinar at http://bit.ly/pharmacyACO.
The document discusses creating a value-based healthcare system focused on patient outcomes and costs. It recommends organizing multidisciplinary teams around patient conditions, measuring outcomes and costs by condition, and developing bundled payments to compensate providers for treating a condition over the full cycle of care. The document also provides an example of Martini Klinik in Germany, which achieves better prostate cancer outcomes than average hospitals through dedicated teams, extensive outcomes tracking, and peer comparison.
Creating transparency in emerging health systemsMohamedKhamis77
SafeCare has developed quality standards and an improvement methodology for benchmarking basic healthcare facilities in low-middle income countries. The standards were approved by ISQua and aim to increase transparency by making medical and financial risks more visible and identifying gaps in quality. This increased transparency builds trust between patients, providers, financers, and governments and paves the way for sustainable investments in quality improvement. By using the SafeCare methodology, key stakeholders are more willing to invest in strengthening health systems. The overall goal is to break the cycle of poor quality and low demand for healthcare by improving scale and access through investments driven by transparency around risks and quality gaps.
MCHA presentation - Lynn Blewett - September 2013soder145
This document summarizes research from a survey of 5,200 enrollees in Minnesota's state high risk pool, MCHA. The survey found that while most enrollees report being generally satisfied with their MCHA coverage, they have high rates of chronic conditions and health care utilization. About half may be eligible for Medicaid or exchange subsidies under the ACA, but many are unfamiliar with the reforms and worried about costs. The researchers recommend a targeted outreach approach to address concerns and educate this population on their new coverage options under the ACA.
Evidence & Implementation of Strategies to Strengthen Health ServicesIDS
This presentation was given by Peters to the International Health Economics Association Conference 2009 in Beijing. It is research conducted as part of the Future Health Systems Research Programme Consortium www.futurehealthsystems.org.
The Addiction Research Foundation seeks to improve treatment outcomes with the primary goal of improving post-treatment quality of life through long-term outcomes research.
The document discusses principles for prioritizing evidence syntheses and making them more useful for decision makers. It emphasizes the importance of reviews being relevant, reliable, and readable. Reviews need to consider context and answer questions relevant to end users. Realist reviews can help understand how complex interventions work in different contexts. Rapid reviews are also important to meet timely decision making needs. Reviews must be methodologically rigorous. They should be presented in accessible formats and highlight information useful for decision making, like costs and applicability to local contexts.
Choosing your career is one of the most important decisions that you will ever make. When asked why they chose to pursue medicine, most physicians respond that they wanted to make a difference by helping people and positively impacting their lives through health care. Serving others as a physician is a noble and challenging way to invest your intellect, skills, and passion in a demanding and rewarding profession.
This document outlines a conference for building cases across state lines related to pharmaceutical drug crimes. It discusses the roles of various practitioners, authorities, investigators and prosecutors involved in these types of cases. It also covers the evolution of the prescription drug epidemic and how prescription drug monitoring programs can aid in multi-state investigations. The document identifies common roadblocks to effective multi-state investigations and the prosecutor's role in working with investigators during early case development.
Making informal health providers work better for the poor: Lessons from Niger...Jeff Knezovich
The document summarizes experiences with informal health providers in Nigeria and Bangladesh and lessons learned from interventions to improve their performance. In both countries, informal providers are an important source of healthcare for the poor but often provide low-quality and unnecessary treatment. Interventions involved training providers, establishing quality standards, and partnerships between organizations. This led to some improvements but also highlighted the need for sustainable business models and strategic leadership given political influences. Ongoing work includes learning platforms to further engage governments and improve market systems for the poor.
CINs (Clinically Integrated Networks) are groups of healthcare providers that work to improve care, reduce costs, and maintain quality standards. They create structures to manage value-based contracts, allow providers to demonstrate value, and integrate physicians and health systems. Key elements of CINs include collaborative physician governance, a focus on population health through data sharing and care management, health IT infrastructure, and aligning provider incentives through value-based contracts and shared savings. Providers commit to engaging with the network, focusing on quality metrics, and using resources to standardize care. In return, CINs provide opportunities for shared savings contracts and support providers through committees and performance feedback.
This document outlines research priorities related to improving health systems and community care. It identifies priorities such as exploring how other jurisdictions have organized health systems to improve outcomes and reduce costs, ensuring the needs of vulnerable populations are met, and redesigning mental health and addiction services to improve access and outcomes. Other priorities include exploring models of integrated health and social services, enhancing care transitions between settings and sectors, developing housing support options, expanding self-management support, and redesigning community care and payment systems to improve care coordination and reduce system utilization.
Dr. Craig J. Lenz - School of Osteopathic MedSamantha Haas
This document discusses barriers to telehealth and opportunities to integrate medical education and telehealth. It describes an early telehealth program in San Bernardino County, California that helped address barriers to care from distance. The document also discusses piloting the use of video conferencing units at a medical school to help deliver certain specialties and clinical education remotely, as well as the potential for students on international clerkships to participate in morning report back at the medical school via laptop or iPad.
This infographic speaks to the challenges Emergency Departments face in caring and following up with the growing population of patients they see, and demonstrates how some EDs are seeing measurable improvements in care, patient satisfaction and efficiency.
Weitzman 2013: PCORI: Transforming Health CareCHC Connecticut
This document summarizes a presentation given by Joe Selby on the Patient-Centered Outcomes Research Institute (PCORI). It discusses PCORI's mission to fund comparative clinical effectiveness research that is guided by patients and other stakeholders. Key points include: PCORI's focus on research questions of interest to patients and providers; its criteria for funding proposals, including patient-centeredness and engagement; and its plans to significantly increase funding for such research over time. Examples are given of funded pilot projects involving community health centers.
General information and trends in continuing medical education (CME), based on Accreditation Council for Continuing Medical Education (ACCME) 2012 Annual Report data and general market analysis for trends impacting education participation.
Study on the Attitude of Medical Partitioners towardAnjum Kazimi
This document summarizes a study on the attitudes of medical practitioners in Pakistan towards social accountability. It describes the study's objectives to investigate medical practitioners' knowledge, attitudes, and practices related to social accountability. The methodology included surveys and interviews with 120 doctors. The results found the practitioners had average knowledge of social accountability but varying attitudes. Their attitudes were not strongly oriented towards social responsibility. The researchers recommend including social accountability training in medical curricula to improve practitioners' knowledge and attitudes.
The document provides a summary of Manjula Sonti's qualifications and experience as a licensed pharmacist. She has over 16 years of experience in retail and hospital pharmacy settings. She is currently pursuing a Master's degree in Health Informatics. Her experience includes managing pharmacy staff and inventory, dispensing and compounding prescriptions, educating patients, and interacting with insurance providers. She has demonstrated leadership, strong communication skills, and a track record of providing quality patient care.
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Parata Systems
Your pharmacy is an excellent partner for accountable care organizations. ACOs are formed by doctors, hospitals and other healthcare providers to improve health outcomes and lower overall medical expenses for a targeted patient population. Reimbursements are tied to patient outcomes.
ACOs’ highest-risk and highest-cost patients are those managing chronic illnesses and taking multiple medications a day. When your pharmacy can improve and track adherence – a key driver of readmission prevention and overall health – you are a valuable partner to help ACOs prevent unnecessary medical care.
Jamie Hale serves as the Chief Pharmacy Officer for Cornerstone Health Care where he is responsible for the development and integration of pharmaceutical care services in the Accountable Care Organization. He transitioned to Cornerstone in December 2012 after a 15 year career at Wake Forest Baptist Health, where he last served as Director of Pharmacy.
Download the full audio webinar at http://bit.ly/pharmacyACO.
The document discusses creating a value-based healthcare system focused on patient outcomes and costs. It recommends organizing multidisciplinary teams around patient conditions, measuring outcomes and costs by condition, and developing bundled payments to compensate providers for treating a condition over the full cycle of care. The document also provides an example of Martini Klinik in Germany, which achieves better prostate cancer outcomes than average hospitals through dedicated teams, extensive outcomes tracking, and peer comparison.
Creating transparency in emerging health systemsMohamedKhamis77
SafeCare has developed quality standards and an improvement methodology for benchmarking basic healthcare facilities in low-middle income countries. The standards were approved by ISQua and aim to increase transparency by making medical and financial risks more visible and identifying gaps in quality. This increased transparency builds trust between patients, providers, financers, and governments and paves the way for sustainable investments in quality improvement. By using the SafeCare methodology, key stakeholders are more willing to invest in strengthening health systems. The overall goal is to break the cycle of poor quality and low demand for healthcare by improving scale and access through investments driven by transparency around risks and quality gaps.
MCHA presentation - Lynn Blewett - September 2013soder145
This document summarizes research from a survey of 5,200 enrollees in Minnesota's state high risk pool, MCHA. The survey found that while most enrollees report being generally satisfied with their MCHA coverage, they have high rates of chronic conditions and health care utilization. About half may be eligible for Medicaid or exchange subsidies under the ACA, but many are unfamiliar with the reforms and worried about costs. The researchers recommend a targeted outreach approach to address concerns and educate this population on their new coverage options under the ACA.
Evidence & Implementation of Strategies to Strengthen Health ServicesIDS
This presentation was given by Peters to the International Health Economics Association Conference 2009 in Beijing. It is research conducted as part of the Future Health Systems Research Programme Consortium www.futurehealthsystems.org.
The Addiction Research Foundation seeks to improve treatment outcomes with the primary goal of improving post-treatment quality of life through long-term outcomes research.
The document discusses principles for prioritizing evidence syntheses and making them more useful for decision makers. It emphasizes the importance of reviews being relevant, reliable, and readable. Reviews need to consider context and answer questions relevant to end users. Realist reviews can help understand how complex interventions work in different contexts. Rapid reviews are also important to meet timely decision making needs. Reviews must be methodologically rigorous. They should be presented in accessible formats and highlight information useful for decision making, like costs and applicability to local contexts.
Choosing your career is one of the most important decisions that you will ever make. When asked why they chose to pursue medicine, most physicians respond that they wanted to make a difference by helping people and positively impacting their lives through health care. Serving others as a physician is a noble and challenging way to invest your intellect, skills, and passion in a demanding and rewarding profession.
This document outlines a conference for building cases across state lines related to pharmaceutical drug crimes. It discusses the roles of various practitioners, authorities, investigators and prosecutors involved in these types of cases. It also covers the evolution of the prescription drug epidemic and how prescription drug monitoring programs can aid in multi-state investigations. The document identifies common roadblocks to effective multi-state investigations and the prosecutor's role in working with investigators during early case development.
The document discusses Baltimore Substance Abuse Systems' (BSAS) efforts to address opioid addiction in Baltimore through expanding access to medication-assisted treatment (MAT) options like buprenorphine and methadone, improving coordination between behavioral health and criminal justice agencies, and developing a recovery-oriented system of care. BSAS aims to ensure high quality substance abuse prevention and treatment services in Baltimore through strategic planning, advocacy, and creating coordinated networks of community-based recovery services.
This document discusses the financial impact of opioid abuse on employers. It identifies the primary causes of increased healthcare costs related to opioid abuse as well as simple steps employers can take to reduce risks and costs. The document explains that prescription drug abuse can impact employers even if they are not currently dealing with issues in their workplace. It provides context on the costs of chronic pain and revenue from opioids. The document examines how cultural factors led to increased opioid prescribing and abuse. It discusses challenges in predicting outcomes for different patients prescribed opioids. Finally, it outlines guiding principles for employers to address opioid abuse, including education, enforcement, oversight, and statutory action if needed.
This document appears to be a presentation about the financial impact of prescription opioid abuse on payers. The presentation identifies prescription drug diversion and abuse as causing increased healthcare costs of up to $27 billion annually. It outlines strategies for payers to address this issue, such as monitoring prescription patterns, using prescription drug monitoring programs, and increasing investigations and prosecutions. While some progress has been made in reducing diversion, the problem remains significant.
This document summarizes key points from a conference on building multi-state cases related to pharmaceutical drug crimes. It discusses the roles of various practitioners, agencies, and prosecutors and how to collaborate across states. It outlines strategies for using prescription drug monitoring programs and issues to consider from a prosecutor's perspective. Tips are provided on working with pharmacists, regulatory authorities, out-of-state partners, and the DEA to strengthen multi-state investigations.
This document summarizes a presentation on medication-assisted treatments for substance use disorders. It discusses the use of medications to treat tobacco, alcohol, and opioid addiction. For tobacco, varenicline is recommended to reduce cravings and prevent relapse. For alcohol, disulfiram, naltrexone, and acamprosate are FDA-approved medications to prevent relapse. Characteristics and considerations for each medication are provided. The benefits of screening and brief interventions in primary care settings are also summarized.
This document summarizes a presentation by Dr. Ileana Arias from the CDC on prescription drug overdoses from a public health perspective. It describes current trends in overdose deaths involving opioid pain relievers, populations most at risk, and the CDC's strategic focus areas and policy recommendations to address the problem using a public health approach. The CDC aims to enhance surveillance, improve clinical practice, and inform policy to help reduce overdose deaths while ensuring appropriate pain treatment.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
This document summarizes a presentation by Dr. Nora Volkow on the growing problem of prescription drug abuse in the United States. Some key points:
- Use and abuse of commonly prescribed opioid and stimulant drugs like Vicodin, OxyContin, Adderall, and Ritalin has been increasing, as seen in rising trends of past year initiation and past month use among Americans aged 12 and older.
- The number of opioid and stimulant prescriptions dispensed by U.S. retail pharmacies has skyrocketed in recent decades, increasing the availability of these potent and addictive medications.
- Younger age groups are particularly at risk, as dentists and emergency physicians are the
Dave Atkinson
Lead on Department of Health’s Positive and Safe Guidance
Independent Consultant Nurse working who led on Department of Health's ' 'Positive and Proactive Care'
This document outlines strategies for building community support for law enforcement efforts to address prescription drug abuse. It describes a conference that brings together law enforcement officials and community partners to discuss prevention strategies. These include assessing local needs and risks, engaging diverse stakeholders, developing strategic plans, implementing evidence-based programs and policies, and continuously evaluating outcomes to improve efforts. The goal is to establish sustainable partnerships and systems to address prescription drug issues through a public health approach.
This document discusses the development of therapeutic guidelines. It defines therapeutic guidelines as clinical practice guidelines written for prescribers to provide treatment recommendations based on current evidence. The document outlines the need for guidelines to improve patient care quality and consistency while controlling healthcare costs. It describes the composition of guideline development groups and the multi-step process involved, including identifying the problem and literature, obtaining expert opinions, reviewing evidence, and disseminating the completed guidelines. Potential limitations of guidelines like complexity and physician acceptance are also discussed.
This document discusses opioid dependence issues faced by health plans and strategies to address them. It identifies barriers to responsible pain management like lack of provider information, skills, and external incentives. Health plans have data on total costs across settings that can identify population problems and inform practices. Strategies for health plans include using data to educate providers, changing policies, and working with providers on care coordination, prior approvals, pharmacy management, and innovative payment models. The best approaches coordinate objective patient information, expert collaboration, and payment reform focused on total cost of care.
The geriatrics pharmacy APPE is a 6-week, full-time rotation focused on providing clinical training and experience caring for elderly patients. The program emphasizes clinical aspects of geriatric pharmacy practice and the interdisciplinary nature of caring for geriatric patients. Students are expected to assess pharmacotherapy appropriateness and safety as well as ensure patients can safely self-administer their medication regimens. The rotation aims to help students apply their knowledge of pharmacology, pharmacokinetics, pathophysiology, and therapeutics to enhance pharmaceutical care for elderly patients.
National statistics show alcohol is the primary substance abused in India at 21.4%, followed by cannabis and opioids. Tobacco use is also high. Transformations in nursing and nursing education have been driven by developments in healthcare and socioeconomic factors. Recent innovations in drug and alcohol treatment focus on speeding withdrawal, incorporating holistic methods like improved nutrition, and customized counseling. Nurses need computer skills and education must respond to changing demographics through diverse and international perspectives. Reasons for innovations include population diversity, health disparities, and technological advances extending life. Major trends are increased regulation as costs rise and applying market forces to contain expenses. Interdisciplinary, team-based approaches improve outcomes and lower costs.
The document outlines state responses to prescription drug and heroin abuse presented at an advocacy track session. It includes presentations from officials in Arizona, Virginia, and New Mexico on their state's strategies. Arizona's presentation focuses on the state's prescriber report cards. Virginia's presentation discusses the governor's task force recommendations and a new health and criminal justice data committee. New Mexico's presentation describes the state's high overdose rates and model of stakeholder collaboration to reduce overdose deaths.
Advocacy Workshop, National Rx Drug Abuse Summit, April 2-4, 2013. Advocacy Workshop: Successful Strategies for Community Change - Part 1 presentation by Dr. Sarah Melton and Dr. Andrew Kolodny.
Krames Patient Education is the only choice for enterprise-wide patient education. In this presentation, practices will learn who Krames Patient Education is and What we can do for you.
We will review Patient-Centered Care and Patient Education; The Case for a Patient Education Investment, The Krames Differencet; Return on Investment; and Krames Solutions.
Generating Quality Data through Collaborative Research with an ACOTodd Berner MD
This document summarizes a presentation about generating quality data through collaborative research with an ACO. The number of public and private ACOs is growing rapidly, with over 250 CMS MSSP ACOs covering 4 million Medicare beneficiaries. The goal of the collaborative research is to disseminate valued information on effectiveness and costs of care to payers and policymakers. Real-world evidence studies can provide insights beyond randomized controlled trials by observing patient outcomes across delivery system models. Measuring quality requires considering multiple stakeholder perspectives to identify metrics that drive improvement and have utility.
Kyle molina harm reduction midterm project unm crp 275 community change in a ...Dr. J
Currently our country is experiencing a national health crisis of opiate use and opiate related overdoses, with the corona virus causing these problems to only get worse. In 2019 the number of drug overdoses in the United States rose by 4.6% , for a total of 70,980, with 50,042 involving opioids (American Hospital Association, 2020)
It is estimated around 130 people die each day due to overdose and since 2010 a total of 400,000 deaths have occurred (DrugAbuse.Gov)
Following national trends New Mexico has seen an increase in reported overdoses since the early 2000s and in 2018 63.0% of drug overdose deaths involved opioids with a total of more than 338 fatalities.(DrugAbuse.Gov)
Transmission of bloodborne diseases such as HIV and Hepatitis C is also an issue among the population who use intravenously.
ROJOSON-PEP-TALK: Strategies of Patient Empowerment Program (Pre-session Reco...Reynaldo Joson
The document discusses strategies for patient empowerment according to ROJoson. ROJoson's strategies are to make patients aware of their rights regarding healthcare management and to educate patients on how to manage their health with or without assistance from healthcare professionals. This education aims to equip patients with basic knowledge, skills, and attitudes to make informed, rational, and cost-effective decisions about their health concerns. ROJoson provides education through one-on-one consultations, group lectures, online learning, blogs, social media, and a weekly PEP Talk on Zoom with a post-session evaluation test.
Ecosystems of prevention: building local practice networks [EUSPR 2016]Mentor
Mentor UK undertook a review of the drug education provision in secondary schools across Brighton and Hove in Sept 2015-Feb 2016 to support evidence-based delivery at a local level. The process not only allowed Mentor to work closely with schools to understand the current capacity and expertise, but also made links and developed strategies to strengthen communication and collaboration with other relevant actors within the community. The case study was presented at this year's EUSPR conference in Berlin, to demonstrate effective strategies to support local agents to implement evidence based practice and develop strong prevention systems.
This document summarizes a presentation on engaging physicians in prevention efforts to address the opioid epidemic. It was presented by Yngvild Olsen and included the following key points:
1. Multiple policies like PDMPs, medication-assisted treatment, and naloxone access need to work together to reduce opioid misuse and overdoses.
2. Programs that educate physicians about prescription drug abuse and its link to heroin, and engage them in prevention, screening, and treatment can help address the epidemic.
3. Expanding access to evidence-based treatment with medications like buprenorphine and naloxone, combined with behavioral therapies, can help manage opioid addiction as a chronic disease
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...Forward360 LLC
Electronic prescribing of controlled substances (EPCS) provides opportunities to improve safety and reduce fraud compared to paper prescriptions. EPCS is now legal in all but two states, though adoption has been limited due to lack of awareness, competing IT priorities, and geographic disparities between enabled pharmacies and providers. Experiences from providers and pharmacies already using EPCS show benefits like increased accountability, accuracy, and reduced costs. Widespread adoption could save up to $700 million annually through improved medication management.
Mentor’s Quality Assurance services provide guidance and tools to support local capacity building through developing and strengthening sustainable prevention networks at a local level. The alcohol and drug education review in Brighton and Hove not only allowed Mentor to work closely with schools to understand the current capacity and expertise, but also made links and developed strategies to strengthen communication and collaboration with other relevant actors within the community.
The document outlines several challenges in mental health care including misconceptions about mental health nursing, a lack of clinical guidelines, challenges in providing care within psychiatric wards, and challenges related to the role of mental health nurses. Some key priorities of the Helsinki Declaration are also summarized such as fostering awareness of mental well-being and collectively tackling stigma. The document discusses scope and role challenges as mental health practice shifts from illness to wellness and deinstitutionalization occurs.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services Administration, keynote presentation at the National Rx Drug Abuse & Heroin Summit March 29, 2016
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
This document discusses the role of health departments in preventing neonatal abstinence syndrome (NAS). It notes that NAS rates have increased significantly in recent years, disproportionately affecting women. Health departments engage in surveillance to monitor NAS trends, partner with other organizations, support treatment and recovery programs, and provide education to prevent NAS, which is entirely preventable. The document outlines specific strategies health departments use across these areas to address the opioid epidemic and protect maternal and infant health.
The document discusses the opioid crisis in the United States, including rising rates of prescription opioid misuse and abuse, as well as heroin use and overdose deaths. It outlines how research can help address this crisis through developing less abusable analgesics, expanding access to treatment medications like naloxone and buprenorphine, and exploring new treatment approaches such as immunotherapies and precision medicine targeting genetic factors. The National Institute on Drug Abuse is supporting these research efforts and working to disseminate findings to improve prevention and intervention programs.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
This presentation covered multi-media prevention strategies for issues like prescription drug overdoses. It discussed the CDC's digital Rx drug prevention campaign, best practices for digital messaging, and programs using expectancy challenge theory and media literacy education in schools. Presenters included representatives from the CDC, Media Literacy for Prevention, and the Hanley Center Foundation who discussed their work developing and implementing digital communications and single-session prevention programs.
This document discusses strategies for reducing buprenorphine diversion and pill mills while improving access to treatment. It notes that limiting access to buprenorphine treatment is associated with increased diversion, while expanded access to quality treatment decreases diversion and overdose deaths. The document recommends educating prescribers, using medically-derived prescribing standards, ensuring adequate insurance coverage of safe prescribing practices, and addressing diversion risks for other controlled medications. It argues against onerous new regulations that could limit treatment access. The goal is to identify and support high-quality treatment while prosecuting criminal operations.
This document summarizes a presentation on linking and mapping prescription drug monitoring program (PDMP) data. It discusses the benefits of linking PDMP data to clinical data, including improving patient safety, evaluating prescribing decisions, and assessing the impact of PDMP interventions. It describes challenges with linking data, such as obtaining consent and negotiating data use agreements. It also discusses Washington State's MAPPING OPIOID AND OTHER DRUG ISSUES (MOODI) tool, which integrates PDMP data with other databases to map and target treatment and overdose prevention efforts at the community level.
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
This document discusses workplace issues related to prescription drug abuse and strategies for prevention. It begins with introductions of the presenters and moderators. The learning objectives are then outlined as understanding challenges of prescription drug abuse in the workplace, identifying prevention strategies, and describing programs available through SAMHSA. The document then covers topics such as the scope of prescription drug misuse among workers, risks to the workplace, prevention strategies employers can consider, and available resources from SAMHSA.
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
This document discusses a presentation on pharmacy burglary, robbery, and diversion of prescription drugs. The presentation covers trends in prescription drug diversion, particularly those involving robbery and burglary of pharmacies. It identifies preventative measures to enhance pharmacy security and safety. Strategies to reduce pharmacy crimes are outlined. The offender perspective is examined based on interviews with convicted offenders. Routine activities theory is discussed as relating to suitable targets, capable guardians, and motivated offenders. Partnerships between regulatory agencies and law enforcement are emphasized as key to prevention efforts.
Linking and mapping PDMP data can provide several benefits but also faces challenges. Linking PDMP and clinical data allows for evaluating the impact of PDMP interventions on outcomes and prescribing decisions. However, obtaining permissions and data is difficult due to legal and resource barriers. Mapping PDMP data using GIS tools in Washington identified areas for targeting overdose prevention efforts by visualizing patterns in prescribing risks, treatment availability, and overdoses. Stakeholders used these maps to guide education and funding decisions. Sustaining these tools requires ongoing funding and expanding included data sources.
This document discusses drug court models and the role of law enforcement in drug courts. It begins with introductions from presenters and outlines learning objectives about explaining drug court operations and benefits, how law enforcement can utilize drug courts, and identifying best practices. The following sections provide details on drug court models, including how they integrate treatment into the justice system using a non-adversarial approach. Key components of drug courts are outlined, and presenters discuss issues like prescription drug and heroin abuse as well as outcomes from drug courts in reducing recidivism and saving money. Law enforcement can play roles in prevention, addressing domestic violence, and targeting the right populations for drug court involvement through assessment.
This document summarizes presentations from two communities - Huntington, WV and Camden County, NJ - on their responses to heroin crises. It outlines programs implemented in Huntington, including a harm reduction program, centralized information system, and drug court expansion. It also discusses the region's history with prescription drug abuse and rise in heroin and associated issues like hepatitis and neonatal abstinence syndrome. Long-term strategies proposed include expanding treatment services, promoting career opportunities for those in recovery, and preventing relapse through environmental design changes.
This document discusses neonatal abstinence syndrome (NAS) and universal maternal drug testing. It provides background information on NAS including trends showing large increases in incidence and costs associated with NAS. It outlines objectives related to describing NAS trends, identifying legislative activities impacting NAS, describing family planning for women in substance abuse treatment, and explaining a hospital program using universal drug testing. The document then covers topics including NAS symptoms, incidence and geographic trends, costs of NAS, opioid use in women of childbearing age, unintended pregnancy rates, contraceptive use among opioid users, and maternal drug exposure sources.
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
This document outlines an advocacy track presentation on activating communities to address prescription drug abuse. It provides biographies of the presenters and moderators and discloses any conflicts of interest. The learning objectives are to identify best practices for implementing CADCA's seven strategies for community change to impact prescription drug issues. It then provides examples of how various coalitions across the country are utilizing each of the seven strategies, such as providing education, enhancing skills, supporting communities, and changing policies.
This document discusses recovery ready ecosystems and recovery community organizations. It introduces presenters from Young People in Recovery and Hope House Treatment Track who will discuss interventions, prevention, and recovery programs. Examples of Young People in Recovery chapters, programs, and services are provided, including employment workshops, education workshops, housing workshops, and recovery support services. The document also discusses recovery community organizations and initiatives in Texas and Georgia, such as the Association of Persons Affected by Addiction in Dallas and the Georgia Council on Substance Abuse.
This document summarizes a presentation on health plan involvement in safe prescribing. It includes:
1) Presentations from medical experts on prescription drug abuse trends from medical examiner data and a tribal health system's safe prescribing program.
2) A discussion of health plan policies to reduce "red flag" medication combinations like opioids plus benzodiazepines through prior authorization, formulary changes, and provider restrictions.
3) Examples of one health plan's implementation of policies like restricting methadone prescriptions to pain specialists and removing carisoprodol from its formulary.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
1. Two Models on New
Approaches for Community-
Based Anti-Drug Coalition:
State of Oregon and
the US Military
April 10-12, 2012
Walt Disney World Swan Resort
2. Learning Objectives:
1. Describe multiple strategies community anti-
drug coalitions in Oregon are employing to
prevent prescription drug abuse.
2. Describe how substance abuse is affecting
our military personnel and their families and
explain the military’s Prevention, Treatment
and Outreach prevention initiative.
3. Specify the successes and challenges of a
variety of prevention strategies and explain
how these strategies can be implemented in
both rural and urban communities.
3. Disclosure Statement
• All presenters for this session, Judy
Cushing and Peggy Quigg, have
disclosed no relevant, real or apparent
personal or professional financial
relationships.
4. THE RX DRUG ABUSE EPIDEMIC –
A State’s Collective Approach
to Policy Change
Judy Cushing CEO
April 10-12, 2012
Walt Disney World Swan Resort
5. Oregon’s Rx Abuse Scene
• High Overdose Rates (400 / year)
• Different Challenges Urban vs. Rural
• High Rates of Student Use
• Glorification of Rx in Pop Culture
• Rx Abuse among Returning Soldiers
And Veterans
6. Statewide Summits 2010 and 2011
Critical Elements:
• Lead by High Level Leaders
• National, State, and
Local Data
• Engaged the Business Community
• Many Coalitions Involved
• Robust Testimony and Dialogue
7. Overview:
Challenges and Opportunities
Prescription Drug Monitoring
• Challenges in Oregon
• Best Practices in Other States
• Third Party Payer Efforts and Experiences
8. Provider Perspectives
• Health Professionals – Best Practices for
Graduate and Undergraduate Training
• Pain Management - Assessing Patients for
Opioid Therapy and Nonopioid Management
• Pharmacists
• Medical and Dental Professionals
• Treatment Community
9. Public Education
• Changing the Norm
Public Education /Outreach
Media
• REMS
Abuse Deterrent Drugs and
FDA’s Safe Use Initiative
• Safe Rx Disposal and Drop Boxes – L/E & DEA
• Employer /HR Training
10. Returning Veterans
• Ease of Access to Rx
• Double Trouble:
Physical and Mental
Trauma and Injury
• Poor access to Treatment
11. Education Leaders
• Who to Engage….
– School Boards
– Administrators / School Leadership
– School Counselors
– Coaches
• How?
– Tool Kit for Educators
– Training
– Professional Development
12. Overarching Summit
Recommendation
Develop and enact statewide policies that
reduces prescription drug abuse, without
restricting safe access, focusing on the
following areas:
13. Recommendation for:
Prescribers: Physicians, Nurse Practitioners
and Physician Assistants
• Assessing risk should be a universal
precaution taken w/ all patients
• Assessment should be incorporated as a
standard practice when prescribing not just
opioids, but with any prescription with
significant abuse potential.
14. Recommendation for:
Health Insurers
• Insurance companies must develop
protocols & implement better training for their
investigators about recognizing and handling
Rx drug diversion
• States can reduce diversion and abuse of
Rx medications, as well as medicaid
expenses, through increased monitoring
15. Recommendations for
Electronic Systems and Controls
• E-prescribing systems must include a
number of safeguards to protect patient
privacy and information security
• Prescription forgery and diversion can
be greatly reduced through an effective
e-prescribing system
16. Recommendations for:
Prescription Monitoring Programs
• Patient confidentiality must be protected
• Health care professionals must be granted
access to data about their patients so they
can conduct an evaluation of patient’s use
• Law enforcement should be allowed
access, but only with probable cause.
17. Recommendations for
Law Enforcement
• Dedicate an investigator to pursue Rx theft, forgery &
manipulation and diversion, possession & illegal distribution of Rx
medications.
• Investigators should work closely with medical experts to
differentiate between a criminal case and a well intentioned
doctor
• Compile data systematically to determine pills diverted through
thefts and losses from the supply chain, the internet, int’l
smuggling, Rx forgery, doctor shopping, and patients selling or
sharing meds
Assign an Officer to the prevention of Rx drug diversion or abuse
18. Recommendations for
Public Education and Advocacy
• Focused education on safe storage and
disposal of prescription medications to prevent
theft and misuse
• Locking medicine cabinets should become
standard practice nationwide
• Pharmacies should stock lockboxes and
encourage consumers to store Rx meds in a
locked box.
19. Recommendations for:
Safe Storage / Responsible Disposal
• A take back program should be
coupled with strong public education
efforts on safe medication disposal.
• A buy back program or pharmacy
coupons in exchange could offer an
incentive to responsible disposal